Amplia Therapeutics Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreatic cancer; and treatment of idiopathic pulmonary fibrosis, as well as ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
1.55
Dividend yield
-
Beta
0.81
Market cap
$66.70M
Enterprise value
$37.92M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.ampliatx.com |
| Mailing address | 90 William Street Level 5 Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 9123 1140 / 61 3 9473 2555 |
Dividends
More: Amplia Therapeutics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Amplia Therapeutics paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ATX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Amplia Therapeutics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Christopher J. Burns B.Sc., BSc(Hons), Ph.D. | CEO, MD & Director | 61 | |
| Mr. Timothy Luscombe B.Com., C.A. | Chief Financial Officer | ||
| Ms. Rhiannon Jones B.Sc., Ph.D. | Chief Operating Officer | ||
| Dr. Jason Lickliter MBBS | Chief Medical Officer | ||
| Mr. Andrew John Cooke FAICS, FCIS, FGIA, L.L.B., MAICD | Company Secretary | 65 |
Profitability and management effectiveness
Profit margin
-158.45%
Operating margin
-166.37%
Return on assets
-17.71%
Return on equity
-28.49%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Amplia Therapeutics is 66.70M and its enterprise value is 37.92M. The enterprise value to revenue ratio of ATX is 7.57. The enterprise value to EBITDA ratio of ATX is -4.56.
The ATX's stocks Beta value is 0.81 making it 19% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Amplia Therapeutics (ATX)
Amplia Therapeutics (ASX:ATX) Frequently Asked Questions
1. What is Amplia Therapeutics's Stock Symbol?
Amplia Therapeutics trades on ASX under the ticker symbol "ATX".
2. What is Amplia Therapeutics's stock price today?
One share of ATX stock can currently be purchased for approximately $0.13.
3. How can I contact Amplia Therapeutics?
Amplia Therapeutics's mailing address is 90 William Street Level 5 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9123 1140.
4. What is Amplia Therapeutics's official website?
The official website of Amplia Therapeutics is https://www.ampliatx.com.